3680
Can Hair Loss Medication Be Enough, or Will You Eventually Need a Hair Transplant in Korea?
작성일
2026-07-10
조회수
8
Many people begin hair loss treatment with medication, only to wonder later: "If my hair is still thinning, should I consider a hair transplant?" Others become concerned when they notice increased shedding after starting minoxidil and worry that the treatment is making things worse.
In reality, these situations are often connected. Hair loss medications, transplantation, and supportive treatments each play different roles, and the right approach depends on the stage of hair loss, donor hair availability, treatment goals, and long-term progression—not on a single symptom alone.
For patients considering a hair transplant in Korea, understanding when medication is enough and when additional treatment may be beneficial is an important part of treatment planning.
One of the most common questions patients ask is:
"I started using minoxidil, but now I'm losing even more hair. Should I stop?"
In many cases, the answer is not necessarily.
Minoxidil may trigger a temporary increase in shedding during the first several weeks of treatment. This phenomenon, commonly called shedding, occurs because resting hairs (telogen hairs) transition more quickly into a new growth cycle (anagen phase). Older hairs are released first, allowing new hairs to grow.
Although seeing more hair fall out can be alarming, temporary shedding does not automatically mean the treatment is harming your hair.
A retrospective study published in the Journal of Dermatological Treatment (2025) found that approximately 57% of patients experienced transient shedding after starting topical minoxidil. Interestingly, patients who experienced shedding showed greater improvement in hair density after six months than those who did not, although both groups demonstrated treatment response. Shedding should therefore be interpreted within the broader clinical context rather than viewed as a sign of treatment failure.
Hair loss medications such as finasteride and minoxidil remain the first-line treatment for androgenetic alopecia because they can slow ongoing hair loss and help preserve existing follicles.
However, medications have limitations.
They generally maintain and strengthen existing hair rather than recreate hair follicles that have already disappeared. Once follicles have been lost permanently, medication alone usually cannot restore significant density.
Medication may also have practical limitations:
For patients with advanced thinning, receding hairlines, or extensive areas where follicles are no longer active, additional treatment options may be considered.
A hair transplant in Korea may become appropriate when medication has stabilized hair loss but cosmetic improvement remains insufficient.
Modern Korean hair transplant techniques, particularly Follicular Unit Extraction (FUE), allow surgeons to redistribute healthy follicles from the donor area to regions affected by permanent hair loss.
A hair transplant consultation in Korea typically considers several factors before recommending surgery:
| Medication May Be Appropriate | Hair Transplant May Be Considered |
|---|---|
| Early-stage thinning | Stable but noticeable bald areas |
| Active follicles remain | Permanent follicle loss |
| Goal is slowing progression | Goal is restoring hairline or density |
| Hair density is still acceptable | Cosmetic coverage is insufficient |
Hair transplantation does not stop future hair loss, which is why medications often remain an important part of long-term management even after surgery.
Not every patient requires immediate surgery. Depending on individual findings, additional therapies may help support scalp health and hair growth.
These may include:
The scientific evidence for these supportive treatments varies, and they are generally considered complementary rather than replacements for established medical therapies.
At NewHair, treatment planning is based on more than the visible amount of hair loss.
For patients seeking a hair transplant in Korea, we evaluate:
Our goal is to recommend the most appropriate combination of treatments rather than automatically proceeding to surgery. In many cases, stabilizing hair loss first leads to more predictable long-term outcomes.
Not necessarily. Temporary shedding can occur as older resting hairs are replaced by new growing hairs. While not everyone experiences shedding, it is generally considered a normal early response rather than proof that treatment is ineffective.
It depends on the stage of hair loss. Medication can slow progression and preserve existing hair, but it usually cannot restore follicles that have already been permanently lost. Some patients eventually require surgery to improve density or restore the hairline.
Patients are generally advised not to discontinue treatment solely because of early shedding without first consulting their physician. The cause of increased hair loss should be evaluated before making changes to treatment.
Yes. A consultation helps determine whether your current treatment is sufficient, whether surgery would provide additional benefit, and how to preserve donor hair for long-term results.
1. Bi, L., Kan, H., Wang, J., Ding, Y., Huang, Y., Wang, C., et al. (2025). Whether the transient hair shedding phase exists after minoxidil treatment and does it predict treatment efficacy? A retrospective study in androgenetic alopecia patients. Journal of Dermatological Treatment, 36(1), 2480739.
2. Rossi, A., Cantisani, C., Melis, L., Iorio, A., Scali, E., & Calvieri, S. Minoxidil Use in Dermatology, Side Effects and Recent Patents. Recent Patents on Inflammation & Allergy Drug Discovery.
3. Gupta, A. K., Mays, R. R., Dotzert, M. S., et al. Efficacy of Low-Level Laser Therapy for Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Written by
Dr.Jino Kim
Outpatient Professor of Plastic Surgery Class at Yonsei University College of Medicine
American Hair Transplantation Qualification (ABHRS)
Executive Director, Korean Society of Plastic Surgeons
Executive Director, Korean Society of Laser Skin Hair (KALDAT)
Executive Director, Korean Medical Laser Association
Full Member of the International Society for Hair Transplantation (ISHRS)